StockData
Immunocore Holdings plc logo

Immunocore Holdings plc (IMCR) stock

IMCRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/3014% below fair value
$27.51−0.30 (-1.08%)

Close on Nov 18, 2026Market cap $1.42BP/E –Yield 0.00%

Immunocore market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Immunocore's market cap was $1.63B on Nov 11, 2026, against $1.99B a year earlier. Over the last 5 years it ranged from $6.02M to $3.48B, with a median of $1.64B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$1.63B-7.0%
2025Dec 31, 2025$1.75B+18.7%
2024Dec 31, 2024$1.48B-55.1%
2023Dec 29, 2023$3.29B+27024.2%
2022Dec 30, 2022$12.11M–

More Immunocore figures

See a number that looks wrong?